Arizona Tribune - Xtant Medical to Issue Fourth Quarter and Year End 2024 Financial Results on March 6, 2025

NYSE - LSE

NGG	1.26%	84.665	$
BCC	0.15%	68.025	$
CMSC	0%	19.47	$
JRI	-0.54%	11.365	$
BCE	1.27%	21.625	$
RIO	-0.19%	83.12	$
GSK	0.84%	50.615	$
BP	0.69%	45.615	$
BTI	0.98%	61.645	$
RYCEF	3.73%	17.98	$
RBGPF	0%	76.02	$
CMSD	-0.15%	19.48	$
RELX	1.48%	40.64	$
AZN	0.5%	185.31	$
VOD	-0.49%	15.415	$

Xtant Medical to Issue Fourth Quarter and Year End 2024 Financial Results on March 6, 2025

BOULEVARD 28.02.2025

BELGRADE, MT / ACCESS Newswire / February 28, 2025 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the fourth quarter and year ended December 31, 2024, after the close of the financial markets on Thursday, March 6, 2025.

Text size:

Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial Officer, will host a conference call on Thursday, March 6, 2025 at 4:30 PM ET to review results.

Conference Details:
Conference Date: Thursday, March 6, 2025
Conference Time: 4:30 PM ET
Conference dial-in: 888-506-0062
International dial-in: 973-528-0011
Passcode: 907938
Conference Call Name: Xtant Medical Q4 and Year End 2024 Financial Results
Webcast Link: https://www.webcaster4.com/Webcast/Page/3039/52116

Following the live call, a replay will be available on the Company's website, https://xtantmedical.com/, under "Investor Info."

About Xtant Medical Holdings, Inc.

Xtant Medical's mission of honoring the gift of donation so that our patients can live as full and complete a life as possible, is the driving force behind our company. Xtant Medical Holdings, Inc. (https://xtantmedical.com/) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.

The symbols™ and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the United States, and in other countries. All other trademarks and trade names referred to in this release are the property of their respective owners.

Investor Relations Contact

Brett Maas • Managing Partner, Hayden IR
[email protected] • (646) 536-7331

SOURCE: Xtant Medical Holdings, Inc.

View the original press release on ACCESS Newswire

R.Garcia--AT

Arizona Tribune - Xtant Medical to Issue Fourth Quarter and Year End 2024 Financial Results on March 6, 2025

Xtant Medical to Issue Fourth Quarter and Year End 2024 Financial Results on March 6, 2025

Featured

Documentary Reveals How Screams Exposed Alleged Camgirl Exploitation Ring

Trustpoint Xposure Launches Program to Help Startup Founders Check How AI Search Platforms Describe Their Companies

Jaguar Health to Hold Investor Webcast November 17 Regarding Q3 2026 Financials & Corporate Updates

InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 13